
Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Magnolia bark extract contains honokiol and magnolol, bioactive compounds that modulate GABA receptors and reduce cortisol levels. These lignans provide anxiolytic and sleep-promoting effects through direct interaction with the central nervous system.

Reported Benefits (Provisional)
Origin & History

Magnolia Bark Extract, particularly honokiol, is derived from the bark of the Magnolia tree, native to China and other parts of Asia. The bark is harvested and processed to extract honokiol, a bioactive compound with therapeutic properties.
Research Narrative (Provisional)
Research, including animal studies and some human trials, supports its use for anxiety reduction and sleep improvement. More clinical trials are needed to confirm cognitive benefits.
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
- Contains honokiol and magnolol, potent bioactive compounds. - Rich in polyphenols with antioxidant properties. - Provides essential oils and alkaloids.
Reported Mechanism (Provisional)
Honokiol acts as a positive allosteric modulator of GABA-A receptors, enhancing chloride ion influx and promoting neural inhibition. The compound also inhibits 5-lipoxygenase and reduces cortisol production by modulating the hypothalamic-pituitary-adrenal axis. Additionally, magnolol increases melatonin synthesis by upregulating N-acetyltransferase activity in the pineal gland.
Clinical Narrative (Provisional)
A randomized controlled trial with 89 participants showed 30% reduction in anxiety scores using 200mg daily magnolia bark extract. Sleep quality studies demonstrate 25% improvement in sleep efficiency with 400mg doses taken before bedtime. Most research consists of small-scale human trials (20-100 participants) and animal studies, indicating promising but limited clinical evidence. Longer-term safety data beyond 12 weeks remains insufficient.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.







